Superluminal – Talk Bio

Actionable Insights Powered by AI

Superluminal Secures $120M Series A Funding to Advance Membrane Receptor Drugs into Clinical Trials

Superluminal, Eli Lilly, Series A funding, membrane receptor drugs, clinical trials, biotech, pharmaceuticals